Eisai recently acquired the rights to distribute EpiTrack® and EpiTrack® Junior which are screening tools for the assessment of cognitive side effects of antiepileptic drugs for the attention and executive functions in people with epilepsy.

These tools are available free of charge to healthcare professionals across Australia, Canada, Europe, Russia and the United States. If you are a healthcare professional and would like more information please contact us.

Post Navigation